Global Post-Traumatic Stress Disorder (PTSD) Market Insights and Forecast to 2028

Q: How big is the posttraumatic stress disorder ptsd market?

Global PostTraumatic Stress Disorder PTSD Market Size Status and Forecast 20212027.Posttraumatic stress disorder PTSD is a delayed and persistent mental disorder that occurs when an individual experiences witnesses or encounters one or more actual deaths involving himself or others or is threatened with death or is severely injured or whose physical integrity is threatened.The incidence of PTSD has been reported inconsistently with women more likely to develop PTSD than men.Market Analysis and Insights Global PostTraumatic Stress Disorder PTSD MarketThe global PostTraumatic Stress Disorder PTSD market size is projected to reach US XX million by 2027 from US XX million in 2020 at a CAGR of XX during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global PostTraumatic Stress Disorder PTSD market to help players in achieving a strong market position.

Q: Who are the key players in the posttraumatic stress disorder ptsd market?

Some of the key players are GlaxoSmithKline UK, Pfizer (US), Eli Lilly and Company (US), Lundbeck A/S (Denmark), Azevan Pharmaceuticals (US), Marinus Pharmaceuticals, Inc. (US), Tonix Pharmaceuticals Holding Corp. (US), Bionomics (Australia), Greenstone LLC (US), Mylan NV (US), Otsuka Pharmaceutical (Japan), Prometheon Pharma (USA), Ligand Pharma (USA), Valenta Pharm (Russia), Lycera Corp (US), Archimedes (UK), GMP Endotherapeutics (USA), Nuvo Pharmaceuticals (Canada), Beijing Wansheng Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Jianfeng Pharmaceutical, China, GMP, Lundbeck, Eli Lilly and Company, Pfizer Inc, Tonix Pharmaceuticals Holding Corp., India, Others.

Code: QYRE-Auto-2L2344

Report

May 2022

127 Pages

QYResearch

Region: Global, North America, Japan, Europe, Central & South America,

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

GlaxoSmithKline UK

Pfizer (US)

Eli Lilly and Company (US)

Lundbeck A/S (Denmark)

Azevan Pharmaceuticals (US)

Marinus Pharmaceuticals, Inc. (US)

Tonix Pharmaceuticals Holding Corp. (US)

Bionomics (Australia)

Greenstone LLC (US)

Mylan NV (US)

Otsuka Pharmaceutical (Japan)

Prometheon Pharma (USA)

Ligand Pharma (USA)

Valenta Pharm (Russia)

Lycera Corp (US)

Archimedes (UK)

GMP Endotherapeutics (USA)

Nuvo Pharmaceuticals (Canada)

Beijing Wansheng Pharmaceutical

Zhejiang Huahai Pharmaceutical

Zhejiang Jianfeng Pharmaceutical

China

GMP

Lundbeck

Eli Lilly and Company

Pfizer Inc

Tonix Pharmaceuticals Holding Corp.

India

Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened.The incidence of PTSD has been reported inconsistently, with women more likely to develop PTSD than men.

Market Analysis and Insights: Global Post-Traumatic Stress Disorder (PTSD) Market

The global Post-Traumatic Stress Disorder (PTSD) market size is projected to reach US$ 3135.3 million by 2028, from US$ 2410.2 million in 2021, at a CAGR of 3.8% during 2022-2028.

Fully considering the economic change by this health crisis, Cognitive Therapy accounting for % of the Post-Traumatic Stress Disorder (PTSD) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Children segment is altered to an % CAGR throughout this forecast period.

China Post-Traumatic Stress Disorder (PTSD) market size is valued at US$ million in 2021, while the North America and Europe Post-Traumatic Stress Disorder (PTSD) are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Post-Traumatic Stress Disorder (PTSD) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post-Traumatic Stress Disorder (PTSD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post-Traumatic Stress Disorder (PTSD) market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post-Traumatic Stress Disorder (PTSD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post-Traumatic Stress Disorder (PTSD) market.

Global Post-Traumatic Stress Disorder (PTSD) Scope and Market Size

Post-Traumatic Stress Disorder (PTSD) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Post-Traumatic Stress Disorder (PTSD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Cognitive Therapy

Exposure Therapy

Eye Movement Desensitization And Reprocessing (EMDR)

Antidepressants

Anti-Anxiety Medications

Prazosin

Segment by Application

Children

Adult

BY COMPANY

GlaxoSmithKline (UK)

Pfizer (US)

Eli Lilly and Company (US)

Lundbeck A/S (Denmark)

Azevan Pharmaceuticals (US)

Marinus Pharmaceuticals, Inc. (US)

Tonix Pharmaceuticals Holding Corp. (US)

Bionomics (Australia)

Greenstone LLC (US)

Mylan NV (US)

Otsuka Pharmaceutical (Japan)

Prometheon Pharma (USA)

Ligand Pharma (USA)

Valenta Pharm (Russia)

Lycera Corp (US)

Archimedes (UK)

GMP Endotherapeutics (USA)

Nuvo Pharmaceuticals (Canada)

Beijing Wansheng Pharmaceutical

Zhejiang Huahai Pharmaceutical

Zhejiang Jianfeng Pharmaceutical

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

GlaxoSmithKline UK

Pfizer (US)

Eli Lilly and Company (US)

Lundbeck A/S (Denmark)

Azevan Pharmaceuticals (US)

Marinus Pharmaceuticals, Inc. (US)

Tonix Pharmaceuticals Holding Corp. (US)

Bionomics (Australia)

Greenstone LLC (US)

Mylan NV (US)

Otsuka Pharmaceutical (Japan)

Prometheon Pharma (USA)

Ligand Pharma (USA)

Valenta Pharm (Russia)

Lycera Corp (US)

Archimedes (UK)

GMP Endotherapeutics (USA)

Nuvo Pharmaceuticals (Canada)

Beijing Wansheng Pharmaceutical

Zhejiang Huahai Pharmaceutical

Zhejiang Jianfeng Pharmaceutical

China

GMP

Lundbeck

Eli Lilly and Company

Pfizer Inc

Tonix Pharmaceuticals Holding Corp.

India

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Cognitive Therapy

1.2.3 Exposure Therapy

1.2.4 Eye Movement Desensitization And Reprocessing (EMDR)

1.2.5 Antidepressants

1.2.6 Anti-Anxiety Medications

1.2.7 Prazosin

1.3 Market by Application

1.3.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Children

1.3.3 Adult

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Perspective (2017-2028)

2.2 Post-Traumatic Stress Disorder (PTSD) Growth Trends by Region

2.2.1 Post-Traumatic Stress Disorder (PTSD) Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Region (2017-2022)

2.2.3 Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Region (2023-2028)

2.3 Post-Traumatic Stress Disorder (PTSD) Market Dynamics

2.3.1 Post-Traumatic Stress Disorder (PTSD) Industry Trends

2.3.2 Post-Traumatic Stress Disorder (PTSD) Market Drivers

2.3.3 Post-Traumatic Stress Disorder (PTSD) Market Challenges

2.3.4 Post-Traumatic Stress Disorder (PTSD) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue

3.1.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue (2017-2022)

3.1.2 Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Players (2017-2022)

3.2 Global Post-Traumatic Stress Disorder (PTSD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder (PTSD) Revenue

3.4 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio

3.4.1 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder (PTSD) Revenue in 2021

3.5 Post-Traumatic Stress Disorder (PTSD) Key Players Head office and Area Served

3.6 Key Players Post-Traumatic Stress Disorder (PTSD) Product Solution and Service

3.7 Date of Enter into Post-Traumatic Stress Disorder (PTSD) Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Post-Traumatic Stress Disorder (PTSD) Breakdown Data by Type

4.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Type (2017-2022)

4.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2023-2028)

5 Post-Traumatic Stress Disorder (PTSD) Breakdown Data by Application

5.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Application (2017-2022)

5.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)

6.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type

6.2.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022)

6.2.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028)

6.2.3 North America Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2017-2028)

6.3 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application

6.3.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022)

6.3.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028)

6.3.3 North America Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2017-2028)

6.4 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country

6.4.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)

6.4.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)

7.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type

7.2.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022)

7.2.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028)

7.2.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2017-2028)

7.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application

7.3.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022)

7.3.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028)

7.3.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2017-2028)

7.4 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country

7.4.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)

7.4.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)

8.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type

8.2.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2017-2028)

8.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application

8.3.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2017-2028)

8.4 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region

8.4.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)

9.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type

9.2.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022)

9.2.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028)

9.2.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2017-2028)

9.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application

9.3.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022)

9.3.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028)

9.3.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2017-2028)

9.4 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country

9.4.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)

9.4.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)

10.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type

10.2.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2017-2028)

10.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application

10.3.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2017-2028)

10.4 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country

10.4.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline (UK)

11.1.1 GlaxoSmithKline (UK) Company Details

11.1.2 GlaxoSmithKline (UK) Business Overview

11.1.3 GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Introduction

11.1.4 GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.1.5 GlaxoSmithKline (UK) Recent Developments

11.2 Pfizer (US)

11.2.1 Pfizer (US) Company Details

11.2.2 Pfizer (US) Business Overview

11.2.3 Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.2.4 Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.2.5 Pfizer (US) Recent Developments

11.3 Eli Lilly and Company (US)

11.3.1 Eli Lilly and Company (US) Company Details

11.3.2 Eli Lilly and Company (US) Business Overview

11.3.3 Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.3.4 Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.3.5 Eli Lilly and Company (US) Recent Developments

11.4 Lundbeck A/S (Denmark)

11.4.1 Lundbeck A/S (Denmark) Company Details

11.4.2 Lundbeck A/S (Denmark) Business Overview

11.4.3 Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Introduction

11.4.4 Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.4.5 Lundbeck A/S (Denmark) Recent Developments

11.5 Azevan Pharmaceuticals (US)

11.5.1 Azevan Pharmaceuticals (US) Company Details

11.5.2 Azevan Pharmaceuticals (US) Business Overview

11.5.3 Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.5.4 Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.5.5 Azevan Pharmaceuticals (US) Recent Developments

11.6 Marinus Pharmaceuticals, Inc. (US)

11.6.1 Marinus Pharmaceuticals, Inc. (US) Company Details

11.6.2 Marinus Pharmaceuticals, Inc. (US) Business Overview

11.6.3 Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.6.4 Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.6.5 Marinus Pharmaceuticals, Inc. (US) Recent Developments

11.7 Tonix Pharmaceuticals Holding Corp. (US)

11.7.1 Tonix Pharmaceuticals Holding Corp. (US) Company Details

11.7.2 Tonix Pharmaceuticals Holding Corp. (US) Business Overview

11.7.3 Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.7.4 Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.7.5 Tonix Pharmaceuticals Holding Corp. (US) Recent Developments

11.8 Bionomics (Australia)

11.8.1 Bionomics (Australia) Company Details

11.8.2 Bionomics (Australia) Business Overview

11.8.3 Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Introduction

11.8.4 Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.8.5 Bionomics (Australia) Recent Developments

11.9 Greenstone LLC (US)

11.9.1 Greenstone LLC (US) Company Details

11.9.2 Greenstone LLC (US) Business Overview

11.9.3 Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.9.4 Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.9.5 Greenstone LLC (US) Recent Developments

11.10 Mylan NV (US)

11.10.1 Mylan NV (US) Company Details

11.10.2 Mylan NV (US) Business Overview

11.10.3 Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.10.4 Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.10.5 Mylan NV (US) Recent Developments

11.11 Otsuka Pharmaceutical (Japan)

11.11.1 Otsuka Pharmaceutical (Japan) Company Details

11.11.2 Otsuka Pharmaceutical (Japan) Business Overview

11.11.3 Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Introduction

11.11.4 Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.11.5 Otsuka Pharmaceutical (Japan) Recent Developments

11.12 Prometheon Pharma (USA)

11.12.1 Prometheon Pharma (USA) Company Details

11.12.2 Prometheon Pharma (USA) Business Overview

11.12.3 Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction

11.12.4 Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.12.5 Prometheon Pharma (USA) Recent Developments

11.13 Ligand Pharma (USA)

11.13.1 Ligand Pharma (USA) Company Details

11.13.2 Ligand Pharma (USA) Business Overview

11.13.3 Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction

11.13.4 Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.13.5 Ligand Pharma (USA) Recent Developments

11.14 Valenta Pharm (Russia)

11.14.1 Valenta Pharm (Russia) Company Details

11.14.2 Valenta Pharm (Russia) Business Overview

11.14.3 Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Introduction

11.14.4 Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.14.5 Valenta Pharm (Russia) Recent Developments

11.15 Lycera Corp (US)

11.15.1 Lycera Corp (US) Company Details

11.15.2 Lycera Corp (US) Business Overview

11.15.3 Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.15.4 Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.15.5 Lycera Corp (US) Recent Developments

11.16 Archimedes (UK)

11.16.1 Archimedes (UK) Company Details

11.16.2 Archimedes (UK) Business Overview

11.16.3 Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Introduction

11.16.4 Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.16.5 Archimedes (UK) Recent Developments

11.17 GMP Endotherapeutics (USA)

11.17.1 GMP Endotherapeutics (USA) Company Details

11.17.2 GMP Endotherapeutics (USA) Business Overview

11.17.3 GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Introduction

11.17.4 GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.17.5 GMP Endotherapeutics (USA) Recent Developments

11.18 Nuvo Pharmaceuticals (Canada)

11.18.1 Nuvo Pharmaceuticals (Canada) Company Details

11.18.2 Nuvo Pharmaceuticals (Canada) Business Overview

11.18.3 Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Introduction

11.18.4 Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.18.5 Nuvo Pharmaceuticals (Canada) Recent Developments

11.19 Beijing Wansheng Pharmaceutical

11.19.1 Beijing Wansheng Pharmaceutical Company Details

11.19.2 Beijing Wansheng Pharmaceutical Business Overview

11.19.3 Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction

11.19.4 Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.19.5 Beijing Wansheng Pharmaceutical Recent Developments

11.20 Zhejiang Huahai Pharmaceutical

11.20.1 Zhejiang Huahai Pharmaceutical Company Details

11.20.2 Zhejiang Huahai Pharmaceutical Business Overview

11.20.3 Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction

11.20.4 Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.20.5 Zhejiang Huahai Pharmaceutical Recent Developments

11.21 Zhejiang Jianfeng Pharmaceutical

11.21.1 Zhejiang Jianfeng Pharmaceutical Company Details

11.21.2 Zhejiang Jianfeng Pharmaceutical Business Overview

11.21.3 Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction

11.21.4 Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

11.21.5 Zhejiang Jianfeng Pharmaceutical Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline UK

Pfizer (US)

Eli Lilly and Company (US)

Lundbeck A/S (Denmark)

Azevan Pharmaceuticals (US)

Marinus Pharmaceuticals, Inc. (US)

Tonix Pharmaceuticals Holding Corp. (US)

Bionomics (Australia)

Greenstone LLC (US)

Mylan NV (US)

Otsuka Pharmaceutical (Japan)

Prometheon Pharma (USA)

Ligand Pharma (USA)

Valenta Pharm (Russia)

Lycera Corp (US)

Archimedes (UK)

GMP Endotherapeutics (USA)

Nuvo Pharmaceuticals (Canada)

Beijing Wansheng Pharmaceutical

Zhejiang Huahai Pharmaceutical

Zhejiang Jianfeng Pharmaceutical

China

GMP

Lundbeck

Eli Lilly and Company

Pfizer Inc

Tonix Pharmaceuticals Holding Corp.

India

List of Tables

Table 1. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Cognitive Therapy

Table 3. Key Players of Exposure Therapy

Table 4. Key Players of Eye Movement Desensitization And Reprocessing (EMDR)

Table 5. Key Players of Antidepressants

Table 6. Key Players of Anti-Anxiety Medications

Table 7. Key Players of Prazosin

Table 8. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 9. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 10. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2017-2022) & (US$ Million)

Table 11. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2017-2022)

Table 12. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 13. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2023-2028)

Table 14. Post-Traumatic Stress Disorder (PTSD) Market Trends

Table 15. Post-Traumatic Stress Disorder (PTSD) Market Drivers

Table 16. Post-Traumatic Stress Disorder (PTSD) Market Challenges

Table 17. Post-Traumatic Stress Disorder (PTSD) Market Restraints

Table 18. Global Post-Traumatic Stress Disorder (PTSD) Revenue by Players (2017-2022) & (US$ Million)

Table 19. Global Post-Traumatic Stress Disorder (PTSD) Revenue Share by Players (2017-2022)

Table 20. Global Top Post-Traumatic Stress Disorder (PTSD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2021)

Table 21. Ranking of Global Top Post-Traumatic Stress Disorder (PTSD) Companies by Revenue (US$ Million) in 2021

Table 22. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue (CR5 and HHI) & (2017-2022)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Post-Traumatic Stress Disorder (PTSD) Product Solution and Service

Table 25. Date of Enter into Post-Traumatic Stress Disorder (PTSD) Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)

Table 28. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2017-2022)

Table 29. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 30. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2023-2028)

Table 31. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)

Table 32. Global Post-Traumatic Stress Disorder (PTSD) Revenue Share by Application (2017-2022)

Table 33. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 34. Global Post-Traumatic Stress Disorder (PTSD) Revenue Share by Application (2023-2028)

Table 35. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)

Table 36. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028) & (US$ Million)

Table 37. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)

Table 38. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028) & (US$ Million)

Table 39. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022) & (US$ Million)

Table 40. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028) & (US$ Million)

Table 41. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)

Table 42. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028) & (US$ Million)

Table 43. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)

Table 44. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028) & (US$ Million)

Table 45. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022) & (US$ Million)

Table 46. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028) & (US$ Million)

Table 47. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)

Table 48. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028) & (US$ Million)

Table 49. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)

Table 50. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028) & (US$ Million)

Table 51. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2017-2022) & (US$ Million)

Table 52. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2023-2028) & (US$ Million)

Table 53. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)

Table 54. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028) & (US$ Million)

Table 55. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)

Table 56. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028) & (US$ Million)

Table 57. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022) & (US$ Million)

Table 58. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028) & (US$ Million)

Table 61. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)

Table 62. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028) & (US$ Million)

Table 63. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022) & (US$ Million)

Table 64. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028) & (US$ Million)

Table 65. GlaxoSmithKline (UK) Company Details

Table 66. GlaxoSmithKline (UK) Business Overview

Table 67. GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Product

Table 68. GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 69. GlaxoSmithKline (UK) Recent Developments

Table 70. Pfizer (US) Company Details

Table 71. Pfizer (US) Business Overview

Table 72. Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Product

Table 73. Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 74. Pfizer (US) Recent Developments

Table 75. Eli Lilly and Company (US) Company Details

Table 76. Eli Lilly and Company (US) Business Overview

Table 77. Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Product

Table 78. Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 79. Eli Lilly and Company (US) Recent Developments

Table 80. Lundbeck A/S (Denmark) Company Details

Table 81. Lundbeck A/S (Denmark) Business Overview

Table 82. Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Product

Table 83. Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 84. Lundbeck A/S (Denmark) Recent Developments

Table 85. Azevan Pharmaceuticals (US) Company Details

Table 86. Azevan Pharmaceuticals (US) Business Overview

Table 87. Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Product

Table 88. Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 89. Azevan Pharmaceuticals (US) Recent Developments

Table 90. Marinus Pharmaceuticals, Inc. (US) Company Details

Table 91. Marinus Pharmaceuticals, Inc. (US) Business Overview

Table 92. Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Product

Table 93. Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 94. Marinus Pharmaceuticals, Inc. (US) Recent Developments

Table 95. Tonix Pharmaceuticals Holding Corp. (US) Company Details

Table 96. Tonix Pharmaceuticals Holding Corp. (US) Business Overview

Table 97. Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Product

Table 98. Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 99. Tonix Pharmaceuticals Holding Corp. (US) Recent Developments

Table 100. Bionomics (Australia) Company Details

Table 101. Bionomics (Australia) Business Overview

Table 102. Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Product

Table 103. Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 104. Bionomics (Australia) Recent Developments

Table 105. Greenstone LLC (US) Company Details

Table 106. Greenstone LLC (US) Business Overview

Table 107. Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Product

Table 108. Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 109. Greenstone LLC (US) Recent Developments

Table 110. Mylan NV (US) Company Details

Table 111. Mylan NV (US) Business Overview

Table 112. Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Product

Table 113. Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 114. Mylan NV (US) Recent Developments

Table 115. Otsuka Pharmaceutical (Japan) Company Details

Table 116. Otsuka Pharmaceutical (Japan) Business Overview

Table 117. Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Product

Table 118. Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 119. Otsuka Pharmaceutical (Japan) Recent Developments

Table 120. Prometheon Pharma (USA) Company Details

Table 121. Prometheon Pharma (USA) Business Overview

Table 122. Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product

Table 123. Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 124. Prometheon Pharma (USA) Recent Developments

Table 125. Ligand Pharma (USA) Company Details

Table 126. Ligand Pharma (USA) Business Overview

Table 127. Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product

Table 128. Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 129. Ligand Pharma (USA) Recent Developments

Table 130. Valenta Pharm (Russia) Company Details

Table 131. Valenta Pharm (Russia) Business Overview

Table 132. Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Product

Table 133. Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 134. Valenta Pharm (Russia) Recent Developments

Table 135. Lycera Corp (US) Company Details

Table 136. Lycera Corp (US) Business Overview

Table 137. Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Product

Table 138. Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 139. Lycera Corp (US) Recent Developments

Table 140. Archimedes (UK) Company Details

Table 141. Archimedes (UK) Business Overview

Table 142. Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Product

Table 143. Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 144. Archimedes (UK) Recent Developments

Table 145. GMP Endotherapeutics (USA) Company Details

Table 146. GMP Endotherapeutics (USA) Business Overview

Table 147. GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Product

Table 148. GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 149. GMP Endotherapeutics (USA) Recent Developments

Table 150. Nuvo Pharmaceuticals (Canada) Company Details

Table 151. Nuvo Pharmaceuticals (Canada) Business Overview

Table 152. Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Product

Table 153. Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 154. Nuvo Pharmaceuticals (Canada) Recent Developments

Table 155. Beijing Wansheng Pharmaceutical Company Details

Table 156. Beijing Wansheng Pharmaceutical Business Overview

Table 157. Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product

Table 158. Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 159. Beijing Wansheng Pharmaceutical Recent Developments

Table 160. Zhejiang Huahai Pharmaceutical Company Details

Table 161. Zhejiang Huahai Pharmaceutical Business Overview

Table 162. Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product

Table 163. Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 164. Zhejiang Huahai Pharmaceutical Recent Developments

Table 165. Zhejiang Jianfeng Pharmaceutical Company Details

Table 166. Zhejiang Jianfeng Pharmaceutical Business Overview

Table 167. Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product

Table 168. Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)

Table 169. Zhejiang Jianfeng Pharmaceutical Recent Developments

Table 170. Research Programs/Design for This Report

Table 171. Key Data Information from Secondary Sources

Table 172. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Type: 2021 VS 2028

Figure 2. Cognitive Therapy Features

Figure 3. Exposure Therapy Features

Figure 4. Eye Movement Desensitization And Reprocessing (EMDR) Features

Figure 5. Antidepressants Features

Figure 6. Anti-Anxiety Medications Features

Figure 7. Prazosin Features

Figure 8. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Application: 2021 VS 2028

Figure 9. Children Case Studies

Figure 10. Adult Case Studies

Figure 11. Post-Traumatic Stress Disorder (PTSD) Report Years Considered

Figure 12. Global Post-Traumatic Stress Disorder (PTSD) Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 13. Global Post-Traumatic Stress Disorder (PTSD) Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 14. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region: 2021 VS 2028

Figure 15. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Players in 2021

Figure 16. Global Top Post-Traumatic Stress Disorder (PTSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2021)

Figure 17. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue in 2021

Figure 18. North America Post-Traumatic Stress Disorder (PTSD) Market Size YoY (2017-2028) & (US$ Million)

Figure 19. North America Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2017-2028)

Figure 20. North America Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2017-2028)

Figure 21. North America Post-Traumatic Stress Disorder (PTSD) Market Size Share by Country (2017-2028)

Figure 22. United States Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. Canada Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 24. Europe Post-Traumatic Stress Disorder (PTSD) Market Size YoY (2017-2028) & (US$ Million)

Figure 25. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2017-2028)

Figure 26. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2017-2028)

Figure 27. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Share by Country (2017-2028)

Figure 28. Germany Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. France Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. U.K. Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Italy Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Russia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Nordic Countries Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size YoY (2017-2028) & (US$ Million)

Figure 35. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2017-2028)

Figure 36. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2017-2028)

Figure 37. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size Share by Region (2017-2028)

Figure 38. China Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Japan Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. South Korea Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. India Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. Australia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 44. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size YoY (2017-2028) & (US$ Million)

Figure 45. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2017-2028)

Figure 46. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2017-2028)

Figure 47. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size Share by Country (2017-2028)

Figure 48. Mexico Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 49. Brazil Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 50. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size YoY (2017-2028) & (US$ Million)

Figure 51. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2017-2028)

Figure 52. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2017-2028)

Figure 53. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size Share by Country (2017-2028)

Figure 54. Turkey Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. Saudi Arabia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. UAE Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 57. GlaxoSmithKline (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 58. Pfizer (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 59. Eli Lilly and Company (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 60. Lundbeck A/S (Denmark) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 61. Azevan Pharmaceuticals (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 62. Marinus Pharmaceuticals, Inc. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 63. Tonix Pharmaceuticals Holding Corp. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 64. Bionomics (Australia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 65. Greenstone LLC (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 66. Mylan NV (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 67. Otsuka Pharmaceutical (Japan) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 68. Prometheon Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 69. Ligand Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 70. Valenta Pharm (Russia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 71. Lycera Corp (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 72. Archimedes (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 73. GMP Endotherapeutics (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 74. Nuvo Pharmaceuticals (Canada) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 75. Beijing Wansheng Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 76. Zhejiang Huahai Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 77. Zhejiang Jianfeng Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)

Figure 78. Bottom-up and Top-down Approaches for This Report

Figure 79. Data Triangulation

Figure 80. Key Executives Interviewed

REPORTS VIEWED RECENTLY

Global Post-Traumatic Stress Disorder (PTSD) Market Insights and Forecast to 2028

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Post-Traumatic Stress Disorder (PTSD) Market Insights and Forecast to 2028

Published Date: May 2022

Report Code: QYRE-Auto-2L2344

Global Post-Traumatic Stress Disorder (PTSD) Market Insights and Forecast to 2028

Code: QYRE-Auto-2L2344

Report

May 2022

127 Pages

QYResearch

Region: Global, North America, Japan, Europe, Central & South America,

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

REPORTS VIEWED RECENTLY

SELECT A FORMAT

Single User

Electronic (PDF)

$4900

Multi User

Electronic (PDF)

$7350

Enterprise User

Electronic (PDF)

$9800

HAVE A QUERY?

OUR CUSTOMER

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-2L2344

Tue May 03 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-5K7905

Tue May 03 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-26Q10074

Tue May 03 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-24S7624

Tue May 03 00:00:00 UTC 2022

Add to Cart

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions